overcame snarled global supply chains to deliver a record number of vehicles in the third quarter. The Silicon Valley electric-vehicle maker’s shares climbed 2.7% premarket.
shares were up 2.8% premarket. Last week, the drug maker said its pill intended to treat Covid-19 had succeeded in a key study.
- Shares of some vaccine makers were extending declines premarket after having dropped last week following the report on Merck’s pill.
was down 4.1% and
shares gained 1.8% premarket.
upgraded its rating of the stock and lifted its price target to $75 a share. It closed Friday at $54.35.
was up 1.6%, having also received a ratings upgrade, from JPMorgan. The bank also nudged its price target up to $85 a share from $84.
shares meanwhile received a ratings downgrade from JPMorgan, and the stock was trading down 1.7% premarket.
- Wine producer
are among the companies reporting earnings Monday.
Chart of the Day
- A quirky corner of the U.S. stock market home to cannabis sellers, cryptocurrency trusts and other speculative investments is seeing record levels of activity.
Write to James Willhite at firstname.lastname@example.org
Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8